• Events
    • EURETINA 2023 Amsterdam
      • Information
      • Exhibition Information
      • Abstract Terms
      • EURETINA Innovation Summit (EIS)
    • EURETINA Innovation Summit (EIS)
      • Information
      • Programme
    • EURETINA 2023 Vilnius (Winter Meeting)
      • Information
      • Programme
      • Registration
      • Hotels
      • Exhibition Information
      • Abstract Viewer
    • EURETINA 2022 Hamburg
      • On Demand
      • Sustainability Plan
      • Main Programme
      • Satellite Symposia
      • Exhibitors
      • Abstract Viewer
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Abstract Viewer
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Committees
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • EBO-Euretina Exam
    • Mentorship Programme
    • RMCR Grant Programme
    • Observership Grant Programme
    • Women in Retina
      • Seeing is Believing Collection
    • YOURS
    • CME Credits
  • Member Login
Menu
  • Events
    • EURETINA 2023 Amsterdam
      • Information
      • Exhibition Information
      • Abstract Terms
      • EURETINA Innovation Summit (EIS)
    • EURETINA Innovation Summit (EIS)
      • Information
      • Programme
    • EURETINA 2023 Vilnius (Winter Meeting)
      • Information
      • Programme
      • Registration
      • Hotels
      • Exhibition Information
      • Abstract Viewer
    • EURETINA 2022 Hamburg
      • On Demand
      • Sustainability Plan
      • Main Programme
      • Satellite Symposia
      • Exhibitors
      • Abstract Viewer
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Abstract Viewer
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Committees
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • EBO-Euretina Exam
    • Mentorship Programme
    • RMCR Grant Programme
    • Observership Grant Programme
    • Women in Retina
      • Seeing is Believing Collection
    • YOURS
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

The RAP study, report 4: Morphological and topographical characteristics of multifocal macular neovascularization type 3

Author: Bilal Haj Najeeb (Austria)

Co-authors: Gabor Deak, Stefan Sacu, Ursula Schmidt-Erfurth, Bianca Gerendas

Purpose

To report on the morphological characteristics and regional distribution of multifocal macular neovascularization type 3 (mMNV3).

Setting/Venue

22 consecutive eyes of 21 patients with mMNV3 were included using multimodal imaging.

Methods

The count and stage of lesions of all MNV types and the existence of exudate and hemorrhage were determined. Also, we addressed the regional distribution of MNV3 lesions between the superior-inferior and the nasal-temporal halves of the macula, and the range of the distance of the lesions from the central fovea. Furthermore, we explored the number of feeding vessels including the cilioretinal artery.

Results

We found 51 lesions in 22 eyes of 21 patients. They were bifocal in 16 (73%) eyes, trifocal in 5(23%) and quadrifocal in one (4%). No lesion of MNV1 or 2 was found. 15 (68%), 2 (9%) and 16 (73%) eyes were associated with retinal hard exudate, sub retinal pigment epithelium exudate and intraretinal hemorrhage, respectively. 30 (59%) lesions were located in the temporal half of the macula, whereas 21 (41%) were located nasally (p=0.07). One (2%) lesion was closer than 500µm, 49 (96%) between 500 and 1500µm and one (2%) between 1500 and 3000µm. The lesions were supplied by one arteriole in one (4%) eye, two arterioles in 16 (73%) eyes and 3 arterioles in 5 (23%) eyes. The CRA contributed as a feeding vessel in 5 (23%) eyes.

Conlusions

The multifocal variant of MNV3 has specific morphological and topographical characteristics. Multimodal imaging allows to understand the pathomorphological condition in more detail.

Financial Disclosure

BHN: Retinsight, unrelated to this study. GD: none. SS: Roche, Novartis, Bayer all unrelated to this study, USE: Bayer/Novartis/Boehringer-Ingelheim/Alcon/Kinarus, all unrelated to this study. BG: Novartis/Kinarus/IDx, all unrelated to this study.

Comments

-

Secretariat Address
European Society of Retina Specialists
Ground Floor, The Apex Building 
Blackthorn Road
Sandyford Business Park
Co Dublin, D18 H6K2

Phone:+353 1 2100092
Email: [email protected]

EURETINA 2023 Amsterdam

EURETINA Innovation Summit (EIS)

Winter Meeting 2023 Vilnius

Abstract Viewer

Forum

Opportunities

Memberships

About

Privacy Policy

Contact Us

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2022 All rights reserved

  • Events
    • EURETINA 2023 Amsterdam
      • Information
      • Exhibition Information
      • Abstract Terms
      • EURETINA Innovation Summit (EIS)
    • EURETINA Innovation Summit (EIS)
      • Information
      • Programme
    • EURETINA 2023 Vilnius (Winter Meeting)
      • Information
      • Programme
      • Registration
      • Hotels
      • Exhibition Information
      • Abstract Viewer
    • EURETINA 2022 Hamburg
      • On Demand
      • Sustainability Plan
      • Main Programme
      • Satellite Symposia
      • Exhibitors
      • Abstract Viewer
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Abstract Viewer
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Committees
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • EBO-Euretina Exam
    • Mentorship Programme
    • RMCR Grant Programme
    • Observership Grant Programme
    • Women in Retina
      • Seeing is Believing Collection
    • YOURS
    • CME Credits
  • Member Login